E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: Relations with clinical variables

British Journal of Oral and Maxillofacial Surgery

Volumn 51, Issue 2, 2013, Pages 149-156

  Rosado, Pablo ^a   Lequerica Fernández, Paloma ^b   Fernández, Soledad ^c   Allonca, Eva ^d   Villallaín, Lucas ^c   De Vicente, Juan C ^c  

^a HOSPITAL DE CABUEÑES   (Spain)

^b HOSPITAL SAN AGUSTÍN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

E cadherin; Immunohistochemistry; Oral squamous cell carcinoma; Catenin

Indexed keywords

BETA CATENIN; UVOMORULIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MODERATELY DIFFERENTIATED ORAL SQUAMOUS CELL CARCINOMA; MOUTH SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; WELL DIFFERENTIATED ORAL SQUAMOUS CELL CARCINOMA; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CELL MEMBRANE; CELL TRANSFORMATION; CYTOPLASM; DRINKING BEHAVIOR; EPITHELIUM; FOLLOW UP; METASTASIS; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; CYTOPLASM; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84883030655     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2012.03.018     Document Type: Article

References (24)

1. Kurtz KA, Hoffman HT, Zimmerman M.B., Robinson RA Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Otolaryngology-Head and Neck Surgery 2006;134:142-6.
2. Downer CS, Speight PM E-cadherin expression in normal, hyperplastic and malignant oral epithelium. European Journal of Cancer Part B: Oral Oncology 1993;29B:303-5.
3. Tanaka N, Odajima T, Ogi K., Ikeda T, Satoh M. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. British Journal of Cancer 2003;89:557-63.
4. Ukpo OC, Thorstad WL, Zhang Q, Lewis Jr JS. Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study. Head and Neck Pathology 2011 [Epub ahead of print, Nov 10].
5. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Current Opinion in Cell Biology 1993;5:806-11.
6. Kudo Y, Kitajima S, Ogawa I., Hiraoka M, Sargolzaei S, Keikhaee M.R., et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clinical Cancer Research 2004;10: 5455-63.
7. Hung KF, Chang CS, Liu C.J., Lui MT, Cheng CY, Kao SY Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2006;35:589-94.
8. Mattijssen V, Peters H, Schalkwijk L., Manni JJ, vant't Hof-Grootenboer B, de Mulder PH, et al. E-cadherin expression in head and neck quamous cell carcinomas is associated with clinical outcome. International Journal of Cancer 1993;55:580-5.
9. Liu LK, Jiang XY, Zhou X.X., Wang DM, Song XL, Jiang HB Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Modern Pathology 2010;23:213-24.
10. Rodrigo JP, Dominguez F, Suárez V, Canel M., Secades P, Chiara MD Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Archives of Otolaryngology-Head and Neck Surgery 2007;133:145-50.
11. Figuero-Ruiz E., Carretero-Peláez MA, Cerero-Lapiedra R, Esparza-Gómez G, Moreno-López LA. Effects of the consumption of alcohol in the oral cavity: relationship with oral cancer (in Spanish and English). Medicina Oral 2004;9:14-23.
12. Hart M, Concordet JP, Lassot I, Albert I., del los Santos R, Durand H, et al. The F-box protein beta-TrCP associates with phosphory-lated beta-catenin and regulates its activity in the cell. Current Biology 1999;9:207-10.
13. Iwai S, Katagiri W, Kong C., Amekawa S, Nakazawa M, Yura Y Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 2005;131:773-82.
14. Kok SH, Lee JJ, Hsu H.C., Chiang CP, Kuo YS, Kuo MY Mutations of the adenomatous polyposis coli gene in areca quid and tobacco-associated oral squamous cell carcinomas in Taiwan. Journal of Oral Pathology and Medicine 2002;31:395-401.
15. Kannan S, Yokozaki H, Jayasree K., Sebastian P, Mathews A, Abraham E.K., et al. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers. International Journal of Oral and Maxillofacial Surgery 2002;31:414-8.
16. Tandle A, Sanghavi V, Saranath D. Infrequent loss of heterozygosity at adenomatous polyposis coli gene locus in Indian oral cancers. Cancer Letters 2000;157:155-60.
17. Mao EJ, Schwartz SM, Daling JR, Beckmann AM. Loss of heterozygosity at 5q21-22 (adenomatous polyposis coli gene region) in oral squamous cell carcinoma is common and correlated with advanced disease. Journal of Oral Pathology and Medicine 1998;27:297-302.
18. Sogabe Y, Suzuki H, Toyota M., Ogi K, Imai T, Nojima M., et al. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. International Journal of Oncology 2008;32: 1253-61.
19. Bagutti C, Speight PM, Watt FM Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. Journal of Pathology 1998;186:8-16.
20. Gao S, Eiberg H, Krogdahl A., Liu CJ, Sørensen JA. Cytoplasmic expression of E-cadherin and beta-catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. Journal of Oral Pathology and Medicine 2005;34: 116-9.
21. Laxmidevi LB, Angadi PV, Pillai R.K., Chandreshekar C. Aberrant β-catenin expression in the histologic differentiation of oral squamous cell carcinoma and verrucous carcinoma: an immunohistochemical study. Journal of Oral Science 2010;52:633-40.
22. Chow V, Yuen AP, Lam K.Y., Tsao GS, Ho WK, Wei WI A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma. Journal of Cancer Research and Clinical Oncology 2001;127:59-63.
23. Bánkfalvi A., Krassort M, Végh A, Felszeghy E., Piffkó J. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. Journal of Oral Pathology and Medicine 2002;31:450-7.
24. Pukkila MJ, Virtaniemi JA, Kumpulainen E.J., Pirinen RT, Johansson RT, Valtonen HJ, et al Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma. Journal of Clinical Pathology 2001;54:42-7.